Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Kuros Biosciences

Market Cap: CHF 894.1m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Gilead Sciences

Market Cap: CHF 163.0b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Sanofi

Market Cap: CHF 89.5b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Gerresheimer

Market Cap: CHF 951.2m

Provides drug containment solutions in Germany and internationally.

Evotec

Market Cap: CHF 606.1m

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Viatris

Market Cap: CHF 20.7b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Pfizer

Market Cap: CHF 142.0b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Bristol-Myers Squibb

Market Cap: CHF 132.5b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Joincare Pharmaceutical Group IndustryLtd

Market Cap: US$18.3b

Joincare Pharmaceutical Group Industry Co.,Ltd.

Basilea Pharmaceutica

Market Cap: CHF 643.3m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

AstraZeneca

Market Cap: CHF 195.9b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Santhera Pharmaceuticals Holding

Market Cap: CHF 212.1m

A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.

Jazz Pharmaceuticals

Market Cap: CHF 16.2b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Merck

Market Cap: US$320.6b

Operates as a healthcare company worldwide.

Tecan Group

Market Cap: CHF 2.3b

Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.

Novartis

Market Cap: CHF 240.6b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Roche Holding

Market Cap: CHF 282.3b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

CRISPR Therapeutics

Market Cap: CHF 4.7b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

Qiagen

Market Cap: CHF 9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Illumina

Market Cap: CHF 20.6b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Roche Holding

Market Cap: CHF 282.3b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Orion Oyj

Market Cap: CHF 11.4b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

MannKind

Market Cap: CHF 1.3b

A biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care.

Johnson & Johnson

Market Cap: CHF 616.5b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Lonza Group

Market Cap: CHF 39.3b

Operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Novavax

Market Cap: CHF 1.2b

A biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally.

Bayer

Market Cap: CHF 47.2b

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.

Idorsia

Market Cap: CHF 1.6b

A biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland, the United States, Japan, Europe, China, and Canada.

Formycon

Market Cap: CHF 339.0m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

Eli Lilly

Market Cap: CHF 1.0t

Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.

Grifols

Market Cap: CHF 5.9b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

Novartis

Market Cap: CHF 240.6b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Newron Pharmaceuticals

Market Cap: CHF 242.6m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Sandoz Group

Market Cap: CHF 28.5b

Develops, manufactures, and markets generic and biosimilars worldwide.

Merck KGaA

Market Cap: CHF 62.2b

Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

MindMaze Therapeutics Holding

Market Cap: CHF 30.4m

Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.